DrugPatentWatch Database Preview
IMODIUM MULTI-SYMPTOM RELIEF Drug Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Which patents cover Imodium Multi-symptom Relief, and what generic alternatives are available?
Imodium Multi-symptom Relief is a drug marketed by J And J Consumer Inc and is included in two NDAs.
The generic ingredient in IMODIUM MULTI-SYMPTOM RELIEF is loperamide hydrochloride; simethicone. There are eleven drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the loperamide hydrochloride; simethicone profile page.
Summary for IMODIUM MULTI-SYMPTOM RELIEF
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Suppliers / Packagers: | 1 |
| Clinical Trials: | 21 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for IMODIUM MULTI-SYMPTOM RELIEF |
| DailyMed Link: | IMODIUM MULTI-SYMPTOM RELIEF at DailyMed |
Recent Clinical Trials for IMODIUM MULTI-SYMPTOM RELIEF
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| McNeil AB | Phase 1 |
| University of North Carolina, Chapel Hill | Phase 2 |
| Allergan | Phase 2 |
Recent Litigation for IMODIUM MULTI-SYMPTOM RELIEF
Identify potential future generic entrants
District Court Litigation
| Case Name | Date |
|---|---|
| ALDERMAN v. MCNEIL-PPC, INC. | 2002-06-27 |
Paragraph IV (Patent) Challenges for IMODIUM MULTI-SYMPTOM RELIEF
| Tradename | Dosage | Ingredient | NDA | Submissiondate |
|---|---|---|---|---|
| IMODIUM MULTI-SYMPTOM RELIEF | TABLET;ORAL | loperamide hydrochloride; simethicone | 021140 | 2004-12-29 |
| IMODIUM MULTI-SYMPTOM RELIEF | TABLET, CHEWABLE;ORAL | loperamide hydrochloride; simethicone | 020606 |
US Patents and Regulatory Information for IMODIUM MULTI-SYMPTOM RELIEF
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J And J Consumer Inc | IMODIUM MULTI-SYMPTOM RELIEF | loperamide hydrochloride; simethicone | TABLET, CHEWABLE;ORAL | 020606-001 | Jun 26, 1996 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| J And J Consumer Inc | IMODIUM MULTI-SYMPTOM RELIEF | loperamide hydrochloride; simethicone | TABLET;ORAL | 021140-001 | Nov 30, 2000 | OTC | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for IMODIUM MULTI-SYMPTOM RELIEF
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| J And J Consumer Inc | IMODIUM MULTI-SYMPTOM RELIEF | loperamide hydrochloride; simethicone | TABLET, CHEWABLE;ORAL | 020606-001 | Jun 26, 1996 | Start Trial | Start Trial |
| J And J Consumer Inc | IMODIUM MULTI-SYMPTOM RELIEF | loperamide hydrochloride; simethicone | TABLET;ORAL | 021140-001 | Nov 30, 2000 | Start Trial | Start Trial |
| J And J Consumer Inc | IMODIUM MULTI-SYMPTOM RELIEF | loperamide hydrochloride; simethicone | TABLET, CHEWABLE;ORAL | 020606-001 | Jun 26, 1996 | Start Trial | Start Trial |
| J And J Consumer Inc | IMODIUM MULTI-SYMPTOM RELIEF | loperamide hydrochloride; simethicone | TABLET;ORAL | 021140-001 | Nov 30, 2000 | Start Trial | Start Trial |
| J And J Consumer Inc | IMODIUM MULTI-SYMPTOM RELIEF | loperamide hydrochloride; simethicone | TABLET, CHEWABLE;ORAL | 020606-001 | Jun 26, 1996 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
